Morningstar Investment Management LLC Sells 36,285 Shares of Danaher Corporation $DHR

Morningstar Investment Management LLC lessened its holdings in shares of Danaher Corporation (NYSE:DHR) by 60.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 23,610 shares of the conglomerate’s stock after selling 36,285 shares during the quarter. Morningstar Investment Management LLC’s holdings in Danaher were worth $5,405,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. JPL Wealth Management LLC bought a new stake in shares of Danaher during the 3rd quarter valued at about $25,000. Elevated Capital Advisors LLC bought a new stake in shares of Danaher during the 4th quarter valued at about $26,000. WFA of San Diego LLC bought a new stake in shares of Danaher during the 2nd quarter valued at about $26,000. ANTIPODES PARTNERS Ltd bought a new stake in shares of Danaher during the 3rd quarter valued at about $27,000. Finally, Financial Life Planners bought a new stake in shares of Danaher during the 3rd quarter valued at about $32,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of NYSE DHR opened at $172.12 on Monday. The stock has a market cap of $121.82 billion, a price-to-earnings ratio of 33.29, a P/E/G ratio of 2.30 and a beta of 0.81. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The stock’s 50-day moving average is $183.52 and its 200 day moving average is $208.70.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.Danaher’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same period last year, the firm posted $1.88 EPS. On average, sell-side analysts anticipate that Danaher Corporation will post 8.43 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is 30.95%.

Analyst Ratings Changes

DHR has been the subject of a number of research analyst reports. Argus dropped their price target on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Friday, April 24th. Jefferies Financial Group reiterated a “buy” rating and set a $245.00 price target on shares of Danaher in a research report on Tuesday, April 21st. Weiss Ratings reiterated a “hold (c)” rating on shares of Danaher in a research report on Friday, March 27th. Wolfe Research decreased their price objective on Danaher from $260.00 to $230.00 and set an “outperform” rating on the stock in a report on Wednesday, April 8th. Finally, Wells Fargo & Company decreased their price objective on Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a report on Wednesday, April 22nd. Nineteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $238.65.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.